Chronic pain medication management of older populations: Key points from a national conference and innovative opportunities for pharmacy practice
| Autor: | Dan I. Lubman, Eleanor van Dyk, Jennifer L. Pilgrim, J. Simon Bell, John J McNeil, Barbara Workman, Julia Gilmartin-Thomas, Rachelle Buchbinder, Melita J. Giummarra, Jenny Gowan, Anneliese Synnot, Stephen J. Gibson, Colin B Chapman, Danny Liew, Carolyn Arnold, Malcolm Dobbin, Matthew McCrone, Flavia M. Cicuttini, Benny Katz |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
business.industry education Chronic pain Pharmaceutical Science Pharmacy medicine.disease Substance abuse 03 medical and health sciences Patient safety 0302 clinical medicine Family medicine Naloxone medicine Pharmacy practice 030212 general & internal medicine Medical prescription business 030217 neurology & neurosurgery Patient education Preventive healthcare medicine.drug |
| Zdroj: | Research in Social and Administrative Pharmacy. 15:207-213 |
| ISSN: | 1551-7411 |
| Popis: | Objective Inappropriate use of pain medication has serious consequences for older populations. Experts in the field have noted an increase in opioid prescriptions, and opioid-related hospitalisations and deaths among this vulnerable population. In the pursuit of educating pharmacists, physicians, allied healthcare professionals, researchers, academics and the public facing the challenges of chronic pain medication management, ‘The Inaugural Monash University School of Public Health and Preventive Medicine (SPHPM) Best Practice in Chronic Pain Medication Management Day Conference’ was held in December 2016 at the Alfred Medical Research and Education Precinct (Melbourne, Australia). Methods Fifteen experts presented on aspects of chronic pain epidemiology and current analgesic use in older Australians, and discussed current practice and associated challenges. Results Presenters highlighted the dramatic increase in opioid prescribing, development of tolerance and withdrawal symptoms, problems with abuse and addiction, increased risk of death from overdose or suicide, potentiation of sedative effects with concurrent use of anxiolytics/hypnotics, and medication diversion. Conclusions Pharmacists are very accessible to patients and are crucial members of medication management teams. They have the necessary medication expertise to review medication regimens and provide patient education. Towards addressing chronic pain medication management of older populations, pharmacists can contribute in several ways, such as being aware of relevant guidelines and completing further training, contributing to policy and guideline development, participating in multidisciplinary panels, working groups and pain management teams, collaborating on research projects, and educating the community. With regards to opioid medication management, pharmacists are in an ideal position to: monitor prescription dispensing and potential misuse, provide education about overuse, and, if appropriate, provide access to naloxone. In order to fulfil these roles and responsibilities, allied healthcare professionals should be educated and informed, and opportunities for continuing professional education should be available and utilised. Pharmacists should have the necessary knowledge and skills to optimise chronic pain management, and to both deliver and inform policies and guidelines on pharmacological management of chronic pain in older people. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect